Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Harper

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|July 19, 1980
Multicentre trials in lung cancerJ S Tobias, R L Souhami, P G Harper, et al.
Thorax|March 1, 1981
What is the best treatment for early operable small cell carcinoma of the bronchus?R L Souhami, P G Harper, D M Geddes, et al.
Clinical Biochemistry|June 1, 1994
Description of an instrument for separation of red cells from plasma and measurement of red cell volumeO Driessen, M S Highley, P G Harper, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Phase II study of Edatrexate in stage III and IV non-small-cell lung cancerR L Souhami, R M Rudd, S G Spiro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
PET and PLAP in suspected testicular cancer relapse: beware sarcoidosisC S Karapetis, A H Strickland, D Yip, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary siteC S Karapetis, D Yip, K Virik, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 18, 2006
Symptomatic responses to neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophagogastric junction: are they worth measuring?M J Forshaw, J A Gossage, K Chrystal, et al.
British Journal of Clinical Pharmacology|January 1, 1991
The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patientsL D Lewis, D L Fitzgerald, P Mohan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistryN A Dobbs, C J Twelves, H Gillies, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Decreased plasma half-life of cyclophosphamide during repeated high-dose administrationM I Graham, I C Shaw, R L Souhami, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|July 19, 1980
Multicentre trials in lung cancerJ S Tobias, R L Souhami, P G Harper, et al.
Thorax|March 1, 1981
What is the best treatment for early operable small cell carcinoma of the bronchus?R L Souhami, P G Harper, D M Geddes, et al.
Clinical Biochemistry|June 1, 1994
Description of an instrument for separation of red cells from plasma and measurement of red cell volumeO Driessen, M S Highley, P G Harper, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Phase II study of Edatrexate in stage III and IV non-small-cell lung cancerR L Souhami, R M Rudd, S G Spiro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
PET and PLAP in suspected testicular cancer relapse: beware sarcoidosisC S Karapetis, A H Strickland, D Yip, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary siteC S Karapetis, D Yip, K Virik, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 18, 2006
Symptomatic responses to neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophagogastric junction: are they worth measuring?M J Forshaw, J A Gossage, K Chrystal, et al.
British Journal of Clinical Pharmacology|January 1, 1991
The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patientsL D Lewis, D L Fitzgerald, P Mohan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistryN A Dobbs, C J Twelves, H Gillies, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Decreased plasma half-life of cyclophosphamide during repeated high-dose administrationM I Graham, I C Shaw, R L Souhami, et al.
Pageof 13